You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 56 Issue 1

July 2003

Volume 56, Issue 1

Pages 1–140

  1. Editor's View

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
      Features of this month's Journal (pages 1–2)

      J. K. Aronson

      Version of Record online: 16 MAY 2007 | DOI: 10.1111/j.1365-2125.2003.1931a.x

  2. Review

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
  3. Pharmacodynamics

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
    2. You have free access to this content
      Pseudoephedrine: effects on milk production in women and estimation of infant exposure via breastmilk (pages 18–24)

      Khalidah Aljazaf, Thomas W. Hale, Kenneth F. Ilett, Peter E. Hartmann, Leon R. Mitoulas, Judith H. Kristensen and L. Peter Hackett

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01822.x

      • image
      • image
  4. Pharmacokinetics

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
      Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya (pages 25–31)

      Alison H. Thomson, Gilbert O. Kokwaro, Simon N. Muchohi, Michael English, Shebbe Mohammed and Geoffrey Edwards

      Version of Record online: 27 JUN 2003 | DOI: 10.1046/j.1365-2125.2003.01819.x

      • image
      • image
      • image
    2. You have free access to this content
      Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction (pages 32–38)

      Jens Rengelshausen, Christoph Göggelmann, Jürgen Burhenne, Klaus-Dieter Riedel, Jochen Ludwig, Johanna Weiss, Gerd Mikus, Ingeborg Walter-Sack and Walter E. Haefeli

      Version of Record online: 27 JUN 2003 | DOI: 10.1046/j.1365-2125.2003.01824.x

      • image
      • image
      • image
    3. You have free access to this content
      Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects (pages 39–45)

      Geraldine M. Ferron, Alain Patat, Virginia Parks, Paul Rolan and Steven M. Troy

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01825.x

      • image
      • image
      • image
    4. You have free access to this content
      A population pharmacokinetic model for paclitaxel in the presence of a novel P-gp modulator, Zosuquidar Trihydrochloride (LY335979) (pages 46–56)

      Sophie Callies, Dinesh P. De Alwis, Adrian Harris, Paul Vasey, Jos H. Beijnen, Jan H. Schellens, Michael Burgess and Leon Aarons

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01826.x

      • image
      • image
      • image
      • image
      • image
      • image
  5. Pharmacokinetics and pharmacodynamics

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
      Physiologically based modelling of inhibition of metabolism and assessment of the relative potency of drug and metabolite: dextromethorphan vs. dextrorphan using quinidine inhibition (pages 57–67)

      A. A. Moghadamnia, A. Rostami-Hodjegan, R. Abdul-Manap, C. E. Wright, A. H. Morice and G. T. Tucker

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01853.x

      • image
      • image
      • imageimage
      • imageimage
  6. Metabolism

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
      CYP2D6, GST-M1 and GST-T1 enzymes: expression in parathyroid gland and association with the parathyroid hormone concentration during early renal replacement therapy (pages 68–77)

      Feng-Xiang Yan, M. Chris Langub, Mark A. Ihnen, Carlton Hornung, Erkki Juronen, Mary K. Rayens, Wei-Min Cai, Peter J. Wedlund and Paolo Fanti

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01832.x

      • image
      • image
      • image
  7. Pharmacogenetics

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
      Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic–genotypic correlates (pages 78–83)

      C. Balram, A. Sharma, C. Sivathasan and Edmund J. D. Lee

      Version of Record online: 27 JUN 2003 | DOI: 10.1046/j.1365-2125.2003.01820.x

      • image
      • image
      • image
  8. Pharmacoepidemiology

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
    2. You have free access to this content
      Antibiotic prescribing for children. Too much and too little? Retrospective observational study in primary care (pages 92–95)

      Suzie Ekins-Daukes, James S. McLay, Michael W. Taylor, Colin R. Simpson and Peter J. Helms

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01835.x

      • image
      • image
      • image
  9. Therapeutics

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
      Development of a dosing strategy for enoxaparin in obese patients (pages 96–103)

      Bruce Green and Stephen B. Duffull

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01849.x

      • image
      • image
      • image
      • image
      • image
    2. You have free access to this content
      Add-on therapy with montelukast or formoterol in patients with the glycine-16 β2-receptor genotype (pages 104–111)

      Erika J. Sims, Catherine M. Jackson and Brian J. Lipworth

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01899.x

      • image
      • image
      • image
  10. Short communications

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
      Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus (pages 112–119)

      Bernhards R. Ogutu, Charles R. J. C. Newton, Simon N. Muchohi, Godfrey O. Otieno, Geoffrey Edwards, William M. Watkins and Gilbert O. Kokwaro

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01829.x

      • image
    2. You have free access to this content
      The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6 (pages 120–124)

      Thomayant Prueksaritanont, Bennett Ma and Nathan Yu

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01833.x

      • image
    3. You have free access to this content
      Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves (pages 125–130)

      Stefan W. Toennes, Sebastian Harder, Markus Schramm, Constanze Niess and Gerold F. Kauert

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01834.x

      • image
    4. You have free access to this content
      Single-dose pharmacokinetics and tolerability of pegylated interferon-α2b in young and elderly healthy subjects (pages 131–134)

      Samir K. Gupta, Paul Glue, Sheila Jacobs, Donna Belle and Melton Affrime

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01836.x

      • image
  11. Letter to the editor

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
      Comparability of whole-blood and plasma clozapine and norclozapine concentrations (pages 135–138)

      R.J. Flanagan, B. Yusufi and T.R.E. Barnes

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01821.x

      • image
  12. Obituary

    1. Top of page
    2. Editor's View
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacokinetics and pharmacodynamics
    7. Metabolism
    8. Pharmacogenetics
    9. Pharmacoepidemiology
    10. Therapeutics
    11. Short communications
    12. Letter to the editor
    13. Obituary
    1. You have free access to this content
      Obituary: David Margerison Davies, 1923–2002 (pages 139–140)

      Hugh de Glanville and Robin Ferner

      Version of Record online: 9 JUL 2003 | DOI: 10.1046/j.1365-2125.2003.01914.x

SEARCH

SEARCH BY CITATION